Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

2021 R&D Spending and Intensity Benchmarks

By: PRLog

VIRGINIA BEACH, Va. - June 6, 2022 - PRLog -- According to a newly released study from Schonfeld & Associates, Inc., R&D Ratios & Budgets, the pharmaceutical industry continued to be the biggest R&D investor in fiscal 2021 with budgets of drug companies increasing by 24% to $168 billion. Software companies increased their spending by a total of over $158 billion.

The biggest single R&D investor in 2021 was Alphabet at over $31 billion, followed by Meta (Facebook) at $24 billion, and then Microsoft and Apple at $21 billion. Firms involved with digital content are investing much more heavily than those in more traditional arenas.

Pharmaceutical firms continued significant R&D spending in 2021. Johnson & Johnson, the top spender at $15.6 billion, is followed by Pfizer, Merck, Bristol Myers Squibb, Astrazeneca and Novartis, each spending over $9 billion. The biotech industry, led by Amgen, grew R&D by over 8% to over $34 billion. Electromedical apparatus makers, led by Medtronic, spent a total of over $3.6 billion, an increase of over nine percent.

R&D budgets of semiconductor makers grew to over $59 billion, an increase of 18.3%. Intel had the largest R&D budget, $15.1 billion, a 12% increase over 2020. R&D budgets within the industries that are major suppliers to the infrastructure of the Internet cloud also have increased R&D spending.

The 2021 R&D spending of the automotive industry, led by Toyota, General Motors and Ford each spending over $7 billion, was up over 26% from the 2020 total with industry revenues up 17.8%.

About the Study

R&D Ratios & Budgets
contains fiscal 2020 and 2021 R&D spending, 2021 revenue and R&D intensity ratio, as well as 2020 and 2021 annual growth rates in R&D spending and sales for over 2,500 firms. Over 290 industry summaries of the same information are provided. The study reports for each company a low and high value for the R&D-to-sales ratio (also known as R&D intensity) for the last five years to indicate stability of R&D spending.

R&D Ratios & Budgets is used for budget planning, monitoring competition, identifying joint venture partners, and spotting acquisition candidates.

The 2022 edition of the PDF report is $ 395 and the report along with Excel datafiles is $ 495. Five years of revenue, R&D spending and ratio information is provided within the datafiles to allow for additional analysis. Contact Schonfeld & Associates, Inc., 1932 Terramar Lane, Virginia Beach, VA 23456. Call for more information: 800-205-0030 or visit the company's web site for immediate download at www.saiBooks.com under Area of Expertise: Research & Development Spending.

Contact
Carol J. Greenhut
***@saibooks.com

Photos: (Click photo to enlarge)

Schonfeld & Associates, Inc. Logo R&D Intensity By Sector

Read Full Story - 2021 R&D Spending and Intensity Benchmarks | More news from this source

Press release distribution by PRLog
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.